Michael Wakabi | 05 Apr 2010 | The East African
Uganda is close to striking a double blow in East Africa's fight against malaria after two of its drug manufacturing plants achieved certification critical to in-country manufacture of new age treatments for the killer disease.
None | 31 Mar 2010 | Daily Nation
A new requirement by the World Health Organisation that all suspected malaria cases be tested before medication is welcome, and the government must move with speed to implement it.
Irene V. Nambi & James Karuhanga | 13 Mar 2010 | New Times (Kigali)
Following the release of new malaria treatment guidelines by the WHO, the acting Director General of TRAC-plus, Dr. Corrine Karema, has noted that Rwanda is ahead of the new recommendations.
Charles Ariko, Edward Anyoli & Justus Akampa | 10 Mar 2010 | New Vision
Three top officials in the Ministry of Health who were in charge of the malaria control programme were yesterday remanded to Luzira Prison after they were charged with corruption.
Mubatsi Asinja Habati | 09 Mar 2010 | The Independent
Rachael Nalubega, 10, sits on her mother's lap near the entrance into one of the children's wards at Uganda's top medical facility, Mulago National Referral Hospital. Nalubega's eyes are motionless and unblinking.
Guy DeLauney | 25 Feb 2010 | BBC News
Parasites are developing resistance to one of the most important anti-malaria drugs, according to experts. Artimisinin has been highly effective, particularly in places where resistance to other drugs has developed.
Cosmas Butunyi | 22 Feb 2010 | The East African
Jolted by reports of poor-quality anti-malaria drugs circulating in parts of eastern Africa, Kenyan health experts are calling for a change of strategy in the fight against malaria.
Irene Nambi | 11 Feb 2010 | New Times (Kigali)
Rwanda's malaria battle has been identified as one of the best practices that other African countries should emulate if the disease is to be eliminated in the near future. These remarks were made by Hans Rietveld, the Director of Global Access
and Marketing in Novartis, a reknown pharmaceutical company in the
None | 08 Feb 2010 | BBC News
Africans suffering from malaria may be getting sub-standard treatment, a study by US-based experts has suggested. Researchers from the Pharmacopeia group found that between 26% and 44% of anti-malaria drugs in Uganda, Senegal and Madagascar were of poor quality.
Ben Okiror | 29 Jan 2010 | New Vision
Several districts are stuck with expired anti-malarial drugs, yet there is a shortage of drugs in health centres and hospitals. The drugs, mostly Homapak, are kept in the stores of the health facilities in the districts, waiting to be collected and destroyed by the National Drug Authority (NDA).